ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow Quality Index
ZhuZhou QianJin Pharmaceutical Co Ltd cash flow quality index. ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Cash Flow Quality Index of 4.84x as of September 2025. Operating cash flow of CN¥288.83 Million exceeds net income of CN¥59.63 Million, indicating high earnings quality where cash backs reported profits. See ZhuZhou QianJin Pharmaceutical Co Ltd (600479) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Cash flow quality index of ZhuZhou QianJin Pharmaceutical Co Ltd from 2002 to 2025. Historical Cash Flow Quality Index for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore ZhuZhou QianJin Pharmaceutical Co Ltd (600479) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2002–2025)
ZhuZhou QianJin Pharmaceutical Co Ltd cash flow quality index by year from 2002 to 2025. Year-by-year earnings quality comparison for ZhuZhou QianJin Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see ZhuZhou QianJin Pharmaceutical Co Ltd (600479) cash flow conversion.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.68x | CN¥480.24 Million | CN¥286.29 Million | ▲ +27.3% |
| 2024 | 1.32x | CN¥398.77 Million | CN¥302.61 Million | ▲ +17.5% |
| 2023 | 1.12x | CN¥443.12 Million | CN¥395.02 Million | ▼ -53.7% |
| 2022 | 2.42x | CN¥733.47 Million | CN¥302.51 Million | ▲ +50.8% |
| 2021 | 1.61x | CN¥485.57 Million | CN¥302.06 Million | ▲ +6.8% |
| 2020 | 1.51x | CN¥542.37 Million | CN¥360.21 Million | ▲ +241.0% |
| 2019 | 0.44x | CN¥155.49 Million | CN¥352.10 Million | ▼ -65.2% |
| 2018 | 1.27x | CN¥383.47 Million | CN¥302.56 Million | ▲ +10.3% |
| 2017 | 1.15x | CN¥283.47 Million | CN¥246.66 Million | ▲ +41.4% |
| 2016 | 0.81x | CN¥140.88 Million | CN¥173.36 Million | ▲ +6.4% |
| 2015 | 0.76x | CN¥67.48 Million | CN¥88.34 Million | ▼ -51.0% |
| 2014 | 1.56x | CN¥183.34 Million | CN¥117.70 Million | ▲ +45.8% |
| 2013 | 1.07x | CN¥137.63 Million | CN¥128.78 Million | ▼ -29.3% |
| 2012 | 1.51x | CN¥197.82 Million | CN¥130.91 Million | ▲ +534.3% |
| 2011 | 0.24x | CN¥22.58 Million | CN¥94.77 Million | ▼ -40.6% |
| 2010 | 0.40x | CN¥39.13 Million | CN¥97.58 Million | ▼ -25.3% |
| 2009 | 0.54x | CN¥73.54 Million | CN¥136.91 Million | ▲ +94.2% |
| 2008 | 0.28x | CN¥37.20 Million | CN¥134.49 Million | ▼ -38.4% |
| 2007 | 0.45x | CN¥79.26 Million | CN¥176.59 Million | ▼ -72.0% |
| 2006 | 1.60x | CN¥120.12 Million | CN¥74.96 Million | ▲ +29.3% |
| 2005 | 1.24x | CN¥76.50 Million | CN¥61.72 Million | ▲ +212.9% |
| 2004 | 0.40x | CN¥18.45 Million | CN¥46.58 Million | ▼ -62.3% |
| 2003 | 1.05x | CN¥50.96 Million | CN¥48.43 Million | ▲ +574.6% |
| 2002 | 0.16x | CN¥6.07 Million | CN¥38.95 Million | — |